{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:01:51Z","timestamp":1779354111547,"version":"3.51.4"},"posted":{"date-parts":[[2021,1,24]]},"group-title":"Microbiology","reference-count":25,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths worldwide and massive societal and economic burden. Recently, a new variant of SARS-CoV-2, known as B.1.1.7, was first detected in the United Kingdom and is spreading in several other countries, heightening public health concern and raising questions as to the resulting effectiveness of vaccines and therapeutic interventions. We and others previously identified host-directed therapies with antiviral efficacy against SARS-CoV-2 infection. Less prone to the development of therapy resistance, host-directed drugs represent promising therapeutic options to combat emerging viral variants as host genes possess a lower propensity to mutate compared to viral genes. Here, in the first study of the full-length B.1.1.7 variant virus, we find two host-directed drugs, plitidepsin (aplidin; inhibits translation elongation factor eEF1A) and ralimetinib (inhibits p38 MAP kinase cascade), as well as remdesivir, to possess similar antiviral activity against both the early-lineage SARS-CoV-2 and the B.1.1.7 variant, evaluated in both human gastrointestinal and lung epithelial cell lines. We find that plitidepsin is over an order of magnitude more potent than remdesivir against both viruses. These results highlight the importance of continued development of host-directed therapeutics to combat current and future coronavirus variant outbreaks.<\/jats:p>","DOI":"10.1101\/2021.01.24.427991","type":"posted-content","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T20:40:10Z","timestamp":1611520810000},"source":"Crossref","is-referenced-by-count":24,"title":["Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-3519","authenticated-orcid":false,"given":"Ann-Kathrin","family":"Reuschl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-6047","authenticated-orcid":false,"given":"Lucy G.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4682-4043","authenticated-orcid":false,"given":"Lorena","family":"Zuliani-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-1427","authenticated-orcid":false,"given":"Mehdi","family":"Bouhaddou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4025-1299","authenticated-orcid":false,"given":"Kirsten","family":"Obernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-9614","authenticated-orcid":false,"given":"Joseph","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-6653","authenticated-orcid":false,"given":"Margaret","family":"Soucheray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M.","family":"Fabius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-6084","authenticated-orcid":false,"given":"Danielle L.","family":"Swaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-4753","authenticated-orcid":false,"given":"Romel","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-0506","authenticated-orcid":false,"given":"Kris M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-7011","authenticated-orcid":false,"given":"Ilsa T.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-8089","authenticated-orcid":false,"given":"James E.","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-4320","authenticated-orcid":false,"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-7211","authenticated-orcid":false,"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8590-7741","authenticated-orcid":false,"given":"Kevan M.","family":"Shokat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-1827","authenticated-orcid":false,"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-2281","authenticated-orcid":false,"given":"Clare","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-0264","authenticated-orcid":false,"given":"Gregory J.","family":"Towers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-337X","authenticated-orcid":false,"given":"Nevan J.","family":"Krogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"3","key":"2024080511063966000_2021.01.24.427991v2.1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The Global Phosphorylation Landscape of SARS-CoV-2 Infection","volume":"182","year":"2020","journal-title":"Cell"},{"key":"2024080511063966000_2021.01.24.427991v2.2","unstructured":"Collier, D. A. , Meng, B. , Ferreira, I. , Datir, R. , The CITIID-NIHR BioResource COVID-19 Collaboration, Temperton, N. , Elmer, A. , Kingston, N. , Graves, B. , McCoy, L. E. , Smith, K. G. C. , Bradley , Thaventhiram, J. , Ceron-Gutierrez, L. , Barcenas-Morales, G. , Wills, M. , Doffinger, R. , & Gupta, R. K. (2021). Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2. medRxiv, 2021.01.19.21249840."},{"key":"2024080511063966000_2021.01.24.427991v2.3","doi-asserted-by":"crossref","unstructured":"Corman, V. M. , Landt, O. , Kaiser, M. , Molenkamp, R. , Meijer, A. , Chu, D. K. W. , Bleicker, T. , Br\u00fcnink, S. , Schneider, J. , Schmidt, M. L. , Mulders, D. G. , Haagmans, B. L. , van der Veer, B. , van den Brink, S. , Wijsman, L. , Goderski, G. , Romette, J.-L. , Ellis, J. , Zambon, M. , \u2026 Drosten, C. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. In Eurosurveillance (Vol. 25, Issue 3). https:\/\/doi.org\/10.2807\/1560-7917.es.2020.25.3.2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"issue":"1","key":"2024080511063966000_2021.01.24.427991v2.4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","article-title":"Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells","volume":"184","year":"2021","journal-title":"Cell"},{"key":"2024080511063966000_2021.01.24.427991v2.5","doi-asserted-by":"crossref","unstructured":"Gordon, D. E. , Hiatt, J. , Bouhaddou, M. , Rezelj, V. V. , Ulferts, S. , Braberg, H. , Jureka, A. S. , Obernier, K. , Guo, J. Z. , Batra, J. , Kaake, R. M. , Weckstein, A. R. , Owens, T. W. , Gupta, M. , Pourmal, S. , Titus, E. W. , Cakir, M. , Soucheray, M. , McGregor, M. , \u2026 Krogan, N. J. (2020). Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, 370 (6521). https:\/\/doi.org\/10.1126\/science.abe9403","DOI":"10.1126\/science.abe9403"},{"key":"2024080511063966000_2021.01.24.427991v2.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9"},{"key":"2024080511063966000_2021.01.24.427991v2.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.12.017"},{"key":"2024080511063966000_2021.01.24.427991v2.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.10.011"},{"issue":"2","key":"2024080511063966000_2021.01.24.427991v2.9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2217\/fon-2018-0492","article-title":"Plitidepsin: a potential new treatment for relapsed\/refractory multiple myeloma","volume":"15","year":"2019","journal-title":"In Future Oncology"},{"issue":"2","key":"2024080511063966000_2021.01.24.427991v2.10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/MMBR.00059-12","article-title":"The Unexpected Roles of Eukaryotic Translation Elongation Factors in RNA Virus Replication and Pathogenesis","volume":"77","year":"2013","journal-title":"In Microbiology and Molecular Biology Reviews"},{"key":"2024080511063966000_2021.01.24.427991v2.11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-59745-394-3_24","article-title":"Measuring HCV infectivity produced in cell culture and in vivo","volume":"510","year":"2009","journal-title":"Methods in Molecular Biology"},{"issue":"4","key":"2024080511063966000_2021.01.24.427991v2.12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2004.05.107","article-title":"Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells","volume":"319","year":"2004","journal-title":"In Biochemical and Biophysical Research Communications"},{"key":"2024080511063966000_2021.01.24.427991v2.13","doi-asserted-by":"crossref","unstructured":"Muik, A. , Wallisch, A. , S\u00e4nger, B. , Swanson, K.A. , M\u00fchl, J. , Chen, W. , Cai, H. , Sarkar, R. , T\u00fcreci, O. , Dormitzer, P.R. , Sahin, U. (2021) Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. BioRxiv: https:\/\/doi.org\/10.1101\/2021.01.18.426984","DOI":"10.1101\/2021.01.18.426984"},{"issue":"5","key":"2024080511063966000_2021.01.24.427991v2.14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1078-0432.CCR-15-1718","article-title":"A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer","volume":"22","year":"2016","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"2024080511063966000_2021.01.24.427991v2.15","unstructured":"Rambaut, A. , Loman, N. , Pybus, O. , Barclay, W. , Barrett, J. , Carabelli, A. , Connor, T. , Peacock, T. , Robertson, D.L. , Volz, E. , on behalf of COVID-19 Genomics Consortium UK (CoG-UK). (2020) Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Report on Virological.org website: https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations\/563."},{"key":"2024080511063966000_2021.01.24.427991v2.16","doi-asserted-by":"crossref","unstructured":"Rathnasinghe, R. , Jangra, S. , Cupic, A. , Mart\u00ednez-Romero, C. , Mulder, L.C. , Kehrer, T. , Yildiz, S. , Choi, A. , Mena, I. , De Vrieze, J. , Aslam, S. , Stadlbauer, D. , Meekins, D.A. , McDowell, C.D. , Balaraman, V. , Richt, J.A. , De Geest, B.G. , Miorin, L. , PVI study group , Krammer, F. , Simon, V. , Garc\u00eda-Sastre, A. , Schotsaert, M. (2021) The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera. MedRxiv: https:\/\/doi.org\/10.1101\/2021.01.19.21249592","DOI":"10.1101\/2021.01.19.21249592"},{"key":"2024080511063966000_2021.01.24.427991v2.17","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P. , Lim, W. S. , Emberson, J. R. , Mafham, M. , Bell, J. L. , Linsell, L. , Staplin, N. , Brightling, C. , Ustianowski, A. , Elmahi, E. , Prudon, B. , Green, C. , Felton, T. , Chadwick, D. , Rege, K. , Fegan, C. , Chappell, L. C. , Faust, S. N. , \u2026 Landray, M. J. (2020). Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. The New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"issue":"3","key":"2024080511063966000_2021.01.24.427991v2.18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS","volume":"27","year":"1938","journal-title":"In American Journal of Epidemiology"},{"key":"2024080511063966000_2021.01.24.427991v2.19","doi-asserted-by":"crossref","unstructured":"Rees-Spear, C. , Muir, L. , Griffith, S.A. , Heaney, J. , Aldon, Y. , Snitselaar, J.L. , Thomas, P. , Graham, C. , Seow, J. , Lee, N. , Rosa, N. , Roustan, C. , Houlihan, C.F. , Sanders, R.W. , Gupta, R. , Cherepanov, P. , Stauss, H. , Nastouli, E. , Doores, K.J , van Gils, M.J. , McCoy, L.E. (2021) The impact of Spike mutations on SARS-CoV-2 neutralization. BioRxiv: https:\/\/doi.org\/10.1101\/2021.01.15.426849.","DOI":"10.1101\/2021.01.15.426849"},{"key":"2024080511063966000_2021.01.24.427991v2.20","doi-asserted-by":"crossref","unstructured":"Thorne, L. G. , Reuschl, A.-K. , Zuliani-Alvarez, L. , Whelan, M. V. X. , Noursadeghi, M. , Jolly, C. , & Towers, G. J. (2020). SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. BioRxiv. https:\/\/doi.org\/10.1101\/2020.12.23.424169","DOI":"10.1101\/2020.12.23.424169"},{"issue":"1","key":"2024080511063966000_2021.01.24.427991v2.21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2019.11.006","article-title":"A randomized, double-blind, placebo-controlled phase 1b\/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer","volume":"156","year":"2020","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"2024080511063966000_2021.01.24.427991v2.22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cell.2020.12.004","article-title":"Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses","volume":"184","year":"2021","journal-title":"Cell"},{"issue":"1","key":"2024080511063966000_2021.01.24.427991v2.23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection","volume":"184","year":"2021","journal-title":"Cell"},{"key":"2024080511063966000_2021.01.24.427991v2.24","doi-asserted-by":"crossref","unstructured":"White, K.M. , Rosales, R. , Yildiz, S. , Kehrer, T. , Miorin, L. , Moreno, E. , Jangra, S. , Uccellini, M. , Rathnasinghe, R. , Coughlan, L. , Martinez-Romero, C. , Batra, J. , Rojc, A. , Bouhaddou, M. , Fabius, J. , Obernier, K. , Dejosez, M. , Guill\u00e9n, M.J. , Losada, A. , Avil\u00e9s, P. , Schotsaert, M. , Zwaka, T. , Vignuzzi, M. , Shokat, K. , Krogan, N.J. , Garc\u00eda-Sastre, A. (2021) Plitidepsin has potent preclinical efficacy against SARS-CoV-2 through inhibition of the host factor eEF1A. Science, In Press: available online 25th of January 2021","DOI":"10.1126\/science.abf4058"},{"issue":"1","key":"2024080511063966000_2021.01.24.427991v2.25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","year":"2005","journal-title":"In Cell Research"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.01.24.427991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:16:30Z","timestamp":1768439790000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2021.01.24.427991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,24]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1101\/2021.01.24.427991","relation":{},"subject":[],"published":{"date-parts":[[2021,1,24]]},"subtype":"preprint"}}